Its a guide, not a standard in itself. I've never read the practical guide so I cannot speak to the specifics of that, but practically speaking, many ISO 13485 certified medical device companies are using paper-based QMS systems. Best practices for GDP. The principles are the same regardless of if you are using Adobe DocuSign or physically signing a piece of paper. ALCOA and ALCOA+ are (from my understanding) primarily used in the pharma industry, but are very much applicable to the medical device industry. The replies above referencing the practical guide even state signatures may be handwritten or electronic.Thank you so much for the insight! I previously worked in a company who had ISO 17025 certification and e-signatures also weren't required.
Do you have any thoughts on one of the above replies regarding the ISO 13485 practical guide?
For example, the signature must be attributable to the individual signing. Adobe DocuSign accomplishes this by having multifactor authentication and verification when an e-signature is applied. For a paper-based system, most companies have signature cards they keep in file that have examples of each employee's signature. That way if there is any doubt, you can pull the signature card to see if the signature matches. ALCOA also states the signature should be enduring. Adobe DocuSign accomplishes this by creating an electronic record of the signature that lives somewhere (my technical knowledge here is limited, perhaps a server?). For physical signatures, enduring would mean use a medium that is indelible.
Electronic signatures are convenient but make sure you consider all costs with them. The software itself is of course the most obvious cost. Don't discount the cost involved with validating the software should you choose that option. Maintaining the validation when new software revisions are released are another often unrealized cost. Whichever you opt for, ensure it meets your internally defined GDP requirements.